Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

186 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Role of multiparametric magnetic resonance imaging in early detection of prostate cancer.
De Visschere PJ, Briganti A, Fütterer JJ, Ghadjar P, Isbarn H, Massard C, Ost P, Sooriakumaran P, Surcel CI, Valerio M, van den Bergh RC, Ploussard G, Giannarini G, Villeirs GM. De Visschere PJ, et al. Among authors: ghadjar p. Insights Imaging. 2016 Apr;7(2):205-14. doi: 10.1007/s13244-016-0466-9. Epub 2016 Feb 4. Insights Imaging. 2016. PMID: 26847758 Free PMC article. Review.
Use of EORTC target definition guidelines for dose-intensified salvage radiation therapy for recurrent prostate cancer: results of the quality assurance program of the randomized trial SAKK 09/10.
Sassowsky M, Gut P, Hölscher T, Hildebrandt G, Müller AC, Najafi Y, Kohler G, Kranzbühler H, Guckenberger M, Zwahlen DR, Azinwi NC, Plasswilm L, Takacs I, Reuter C, Sumila M, Manser P, Ost P, Böhmer D, Pilop C, Aebersold DM, Ghadjar P. Sassowsky M, et al. Among authors: ghadjar p. Int J Radiat Oncol Biol Phys. 2013 Nov 1;87(3):534-41. doi: 10.1016/j.ijrobp.2013.06.2053. Epub 2013 Aug 22. Int J Radiat Oncol Biol Phys. 2013. PMID: 23972722 Clinical Trial.
Multimodal treatment for high-risk prostate cancer with high-dose intensity-modulated radiation therapy preceded or not by radical prostatectomy, concurrent intensified-dose docetaxel and long-term androgen deprivation therapy: results of a prospective phase II trial.
Guttilla A, Bortolus R, Giannarini G, Ghadjar P, Zattoni F, Gnech M, Palumbo V, Valent F, Garbeglio A, Zattoni F. Guttilla A, et al. Among authors: ghadjar p. Radiat Oncol. 2014 Jan 14;9:24. doi: 10.1186/1748-717X-9-24. Radiat Oncol. 2014. PMID: 24423462 Free PMC article. Clinical Trial.
Preferences in the management of high-risk prostate cancer among urologists in Europe: results of a web-based survey.
Surcel CI, Sooriakumaran P, Briganti A, De Visschere PJ, Fütterer JJ, Ghadjar P, Isbarn H, Ost P, Ploussard G, van den Bergh RC, van Oort IM, Yossepowitch O, Sedelaar JP, Giannarini G; Members of Prostate Cancer Working Group of Young Academic Urologists Working Party; Members of Young Urologists Office of European Association of Urology. Surcel CI, et al. Among authors: ghadjar p. BJU Int. 2015 Apr;115(4):571-9. doi: 10.1111/bju.12796. Epub 2014 Aug 11. BJU Int. 2015. PMID: 24802335
The oncologic role of local treatment in primary metastatic prostate cancer.
Ghadjar P, Briganti A, De Visschere PJ, Fütterer JJ, Giannarini G, Isbarn H, Ost P, Sooriakumaran P, Surcel CI, van den Bergh RC, van Oort IM, Yossepowitch O, Ploussard G. Ghadjar P, et al. World J Urol. 2015 Jun;33(6):755-61. doi: 10.1007/s00345-014-1347-9. Epub 2014 Jul 5. World J Urol. 2015. PMID: 24997127 Review.
Prognostic effect of neuroendocrine differentiation in prostate cancer: A critical review.
Surcel CI, van Oort IM, Sooriakumaran P, Briganti A, De Visschere PJ, Fütterer JJ, Ghadjar P, Isbarn H, Ost P, van den Bergh RC, Yossepowitch O, Giannarini G, Ploussard G; Members of the Prostate Cancer Working Group of the Young Academic Urologists Working Party of the European Association of Urology. Surcel CI, et al. Among authors: ghadjar p. Urol Oncol. 2015 Jun;33(6):265.e1-7. doi: 10.1016/j.urolonc.2014.08.007. Epub 2014 Sep 17. Urol Oncol. 2015. PMID: 25238700 Review.
What is the optimal definition of misclassification in patients with very low-risk prostate cancer eligible for active surveillance? Results from a multi-institutional series.
Gandaglia G, Ploussard G, Isbarn H, Suardi N, De Visschere PJ, Futterer JJ, Ghadjar P, Massard C, Ost P, Sooriakumaran P, Surcel CI, van der Bergh RC, Montorsi F, Ficarra V, Giannarini G, Briganti A; Prostate Cancer Working Group of Young Academic Urologists Working Party of European Association of Urology. Gandaglia G, et al. Among authors: ghadjar p. Urol Oncol. 2015 Apr;33(4):164.e1-9. doi: 10.1016/j.urolonc.2014.12.011. Epub 2015 Jan 22. Urol Oncol. 2015. PMID: 25620154
Systematic ultrasound-guided saturation and template biopsy of the prostate: indications and advantages of extended sampling.
Isbarn H, Briganti A, De Visschere PJ, Fütterer JJ, Ghadjar P, Giannarini G, Ost P, Ploussard G, Sooriakumaran P, Surcel CI, van Oort IM, Yossepowitch O, van den Bergh RC; Prostate Cancer Working Group of the European Association of Urology Young Academic Urologists. Isbarn H, et al. Among authors: ghadjar p. Arch Esp Urol. 2015 Apr;68(3):296-306. Arch Esp Urol. 2015. PMID: 25948801 Review.
Clinical Perspectives from Randomized Phase 3 Trials on Prostate Cancer: An Analysis of the ClinicalTrials.gov Database.
Tsikkinis A, Cihoric N, Giannarini G, Hinz S, Briganti A, Wust P, Ost P, Ploussard G, Massard C, Surcel CI, Sooriakumaran P, Isbarn H, De Visschere PJL, Futterer JJ, van der Bergh RCN, Dal Pra A, Aebersold DM, Budach V, Ghadjar P. Tsikkinis A, et al. Among authors: ghadjar p. Eur Urol Focus. 2015 Sep;1(2):173-184. doi: 10.1016/j.euf.2015.05.003. Epub 2015 Jun 6. Eur Urol Focus. 2015. PMID: 28723431
186 results